<DOC>
	<DOCNO>NCT01286181</DOCNO>
	<brief_summary>Although drug therapy pulmonary rehabilitation greatly improve COPD symptom , many 50 % patient severe COPD inadequately control dyspnea . Device-guided breathe behavioral intervention guide respiratory rate therapeutic range ; prolongation expiratory phase improve hyperinflation , significant driver dyspnea population . Device-guided breathing , know side-effects , may represent cost effective adjunctive treatment dyspnea severe COPD .</brief_summary>
	<brief_title>Device-guided Breathing Shortness Breath COPD</brief_title>
	<detailed_description />
	<mesh_term>Dyspnea</mesh_term>
	<criteria>Current former cigarette smoker least 10 packyears Clinically significant dyspnea , determine score least 2 Medical Research Council Dyspnea Score questionnaire ( 04 ) , pulmonary function test result residual volume ( RV ) &gt; 150 % predict FEV1 &lt; 65 % predict Clinical diagnosis chronic obstructive pulmonary disease Unable use slowbreathing device due hearing impairment Poor motivation lack interest use device Pulmonary Rehabilitation order new therapy time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>Biofeedback</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Quality life</keyword>
	<keyword>Stress</keyword>
</DOC>